Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with Peripheral Arterial Disease：Phase II

NCT06850207 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT06850207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06850207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with Peripheral Arterial Disease：Phase II
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
January 31, 2029
Enrollment
6,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease(pad)